Catherine Coste is Director of MINERVA SURGICAL INC. Currently has a direct ownership of 129,579 shares of UTRS, which is worth approximately $1,295. The most recent transaction as insider was on Jun 10, 2022, when has been sold 49,792 shares (Common Stock) at a price of $2.41 per share, resulting in proceeds of $119,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130K
0% 3M change
0% 12M change
Total Value Held $1,295

Catherine Coste Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2022
BUY
Grant, award, or other acquisition
$119,999 $2.41 p/Share
49,792 Added 27.76%
129,579 Common Stock

Also insider at

RNLX
Renalytix plc Healthcare
BMRA
BIOMERICA INC Healthcare
CC

Catherine Coste

Director
Irvine, CA

Track Institutional and Insider Activities on UTRS

Follow MINERVA SURGICAL INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTRS shares.

Notify only if

Insider Trading

Get notified when an Minerva Surgical Inc insider buys or sells UTRS shares.

Notify only if

News

Receive news related to MINERVA SURGICAL INC

Track Activities on UTRS